1-3 of 3
William S. Denney
Close
Sort by
Journal Articles

Hyper-Sialylated IgG M254, an Innovative Therapeutic Candidate, Evaluated in Healthy Volunteers and in Patients with Immune Thrombocytopenia Purpura: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

Santiago Arroyo, MD PhD, Renger G Tiessen, MD, William S Denney, PhD, Jim Jin, MS, Mattheus Paulus (Thijs) van Iersel, MD, Heidi Zeitz, MD CCRA, Anthony M Manning, PhD, Martin R. Schipperus, MD PhD, James B. Bussel, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1090.
https://doi.org/10.1182/blood-2019-125993
Published: 2019
Journal Articles

A Quantitative Systems Pharmacology Model for the Coagulation Network Describes Biomarker Changes Observed in a Clinical Study with FXa Variant and Predicts Age-Associated Biomarker Variations

Satyaprakash Nayak, PhD, Dooyoung Lee, PhD, Steven Arkin, MD, Steven W. Martin, PhD, Anne C. Heatherington, PhD, William S. Denney, PhD, Paolo Vicini, PhD, Fei Hua, PhD
Journal: Blood
Blood (2015) 126 (23): 3502.
https://doi.org/10.1182/blood.V126.23.3502.3502
Published: 2015
Journal Articles

Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow

Uzoma M. Okorie, William S. Denney, Manash S. Chatterjee, Keith B. Neeves, Scott L. Diamond
Journal: Blood
Blood (2008) 111 (7): 3507–3513.
https://doi.org/10.1182/blood-2007-08-106229
Published: 2008
Includes: Supplemental data